For the second episode of the KDIGO IgA Nephropathy (IgAN) podcast series, Dr. Dana Rizk and Dr. Shikha Wadhwani discuss the IgAN treatment revolution. The conversation explores how a deeper understanding of the disease's pathophysiology has led to new therapeutic options, moving beyond traditional supportive care.

Key topics include:

• The shift in IgAN treatment since the KDIGO 2021 guidelines
  
• The four-hit hypothesis of IgAN, and how new therapies are being developed to target each step of the disease's pathogenesis
  
• Factors for clinicians to consider when choosing new treatments
  
• The evolving role of traditional therapies alongside newer agents

This episode was supported by Travere